Testing the use of blood plasma as a treatment and preventive measure against COVID-19 in Wisconsin
Return to Listing
COVID-19 has killed more than 33,000 individuals globally and more than 2,300 Americans. In Wisconsin, the rate of COVID-19 is exponentially increasing. Given widespread community transmission, prevention of disease spread now ultimately depends on effective treatment to limit the number of individuals who can spread the disease. One potential treatment is collecting convalescent plasma from the blood of recovered patients and infusing it into another person to give them the antibodies to fight or prevent infection.
The goal of this project, a joint effort between Versiti and MCW, is to identify, obtain, and provide convalescent plasma from recovered patients with COVID-19 to patients with active disease and, as a prevention, to frontline health care workers.
Community Partner: Versiti Wisconsin, Inc.
8701 W Watertown Plank Road,
Milwaukee, WI 53226-0509
Governance and Reporting
Maps & Directions
©2021 MEDICAL COLLEGE OF WISCONSIN. ALL RIGHTS RESERVED | MCW.EDU | TERMS & PRIVACY | NON-DISCRIMINATION NOTICE